Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Contributor

Sarah Verna

Sarah Verna is product manager of drug discovery at Thermo Fisher Scientific.

More GEN Content From This Contributor

No contributions

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll